Risk of male breast cancer in users of testosterone 5a reductase inhibitors
(2016) 2016 Annual Meeting of the American Society of Clinical Oncology In Journal of Clinical Oncology 34(Suppl 15).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/b926fddd-582f-4212-9653-b63d2c0e532f
- author
- Olsson, H.L. LU ; Lindahl, J. LU and Broberg, P. LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- adrenergic receptor blocking agent, androgen receptor, BRCA2 protein, steroid 5alpha reductase, cancer diagnosis, cancer registry, controlled study, death, diagnosis, drug exposure, gene inactivation, gene mutation, gynecomastia, human, logistic regression analysis, major clinical study, male, male breast cancer, population based case control study, proportional hazards model, prostate cancer, prostate hypertrophy, side effect
- in
- Journal of Clinical Oncology
- volume
- 34
- issue
- Suppl 15
- publisher
- American Society of Clinical Oncology
- conference name
- 2016 Annual Meeting of the American Society of Clinical Oncology
- conference location
- Chicago, IL, United States
- conference dates
- 2016-06-03 - 2016-06-07
- ISSN
- 1527-7755
- language
- English
- LU publication?
- yes
- id
- b926fddd-582f-4212-9653-b63d2c0e532f
- alternative location
- https://ascopubs.org/toc/jco/34/15_suppl
- date added to LUP
- 2021-10-28 16:35:05
- date last changed
- 2021-10-29 11:13:28
@misc{b926fddd-582f-4212-9653-b63d2c0e532f, author = {{Olsson, H.L. and Lindahl, J. and Broberg, P.}}, issn = {{1527-7755}}, keywords = {{adrenergic receptor blocking agent; androgen receptor; BRCA2 protein; steroid 5alpha reductase; cancer diagnosis; cancer registry; controlled study; death; diagnosis; drug exposure; gene inactivation; gene mutation; gynecomastia; human; logistic regression analysis; major clinical study; male; male breast cancer; population based case control study; proportional hazards model; prostate cancer; prostate hypertrophy; side effect}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{Suppl 15}}, publisher = {{American Society of Clinical Oncology}}, series = {{Journal of Clinical Oncology}}, title = {{Risk of male breast cancer in users of testosterone 5a reductase inhibitors}}, url = {{https://ascopubs.org/toc/jco/34/15_suppl}}, volume = {{34}}, year = {{2016}}, }